The additional shipments, which add to an existing supply agreement between the two companies, will be completed later this year.
Geron's cancer drug is a thio-phosporamidate oligonucleotide, for which Transgenomic provides the building blocks.
The additional shipments, which add to an existing supply agreement between the two companies, will be completed later this year.
Geron's cancer drug is a thio-phosporamidate oligonucleotide, for which Transgenomic provides the building blocks.